Cambridge Investment Research Advisors’s Wgl Holdings WGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,361
Closed -$1.01M 2353
2018
Q2
$1.01M Sell
11,361
-737
-6% -$64.2K 0.01% 970
2018
Q1
$1.01M Sell
12,098
-1,979
-14% -$166K 0.01% 934
2017
Q4
$1.21M Sell
14,077
-138
-1% -$11.8K 0.01% 816
2017
Q3
$1.2M Buy
14,215
+535
+4% +$45.2K 0.02% 764
2017
Q2
$1.14M Sell
13,680
-321
-2% -$26.6K 0.02% 746
2017
Q1
$1.16M Sell
14,001
-92
-0.7% -$7.49K 0.02% 668
2016
Q4
$1.07M Sell
14,093
-885
-6% -$59.6K 0.02% 639
2016
Q3
$939K Sell
14,978
-1,116
-7% -$74.3K 0.02% 719
2016
Q2
$1.14M Buy
16,094
+1,264
+9% +$85.6K 0.02% 549
2016
Q1
$1.07M Sell
14,830
-143
-1% -$9.56K 0.02% 542
2015
Q4
$943K Buy
14,973
+1,395
+10% +$85.1K 0.02% 570
2015
Q3
$783K Buy
13,578
+8,801
+184% +$484K 0.02% 563
2015
Q2
$259K Buy
+4,777
New +$267K 0.01% 1136
2013
Q3
Sell
-6,983
Closed -$302K 1241
2013
Q2
$302K Buy
+6,983
New +$308K 0.02% 757

Other funds holding WGL

Cambridge Investment Research Advisors's WGL Position: Q3 2018 in Review

Cambridge Investment Research Advisors sold out of Wgl Holdings (WGL) in Q3 2018, closing a stake of 11,361 shares — an estimated $1.01M sold.

Cambridge Investment Research Advisors first reported a position in WGL in Q2 2013 and held it in 14 quarters. The position peaked at $1.21M in Q4 2017. 2 funds tracked by Wall St. Rank hold WGL as of Q3 2018.

  • Cambridge Investment Research Advisors reported no remaining Wgl Holdings position as of Q3 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,361 Wgl Holdings shares in Q3 2018, an estimated $1.01M.
  • Cambridge Investment Research Advisors first reported a position in Wgl Holdings in Q2 2013 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Wgl Holdings position peaked at $1.21M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Wgl Holdings as of Q3 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.